riskcardio
Using machine learning to estimate risk of cardiovascular death
Humans are inherently risk-averse: We spend our days calculating routes and routines, taking precautionary measures to avoid disease, danger, and despair. Still, our measures for controlling the inner workings of our biology can be a little more unruly. With that in mind, a team from MIT's Computer Science and Artificial Intelligence Laboratory (CSAIL) came up with a new system for better predicting health outcomes: a machine learning model that can estimate, from the electrical activity of their heart, a patient's risk of cardiovascular death. The system, called "RiskCardio," focuses on patients who have survived an acute coronary syndrome (ACS), which refers to a range of conditions where there's a reduction or blockage of blood to the heart. Using just the first 15 minutes of a patient's raw electrocardiogram (ECG) signal, the tool produces a score that places patients into different risk categories.
AI will read ECG, detect heart attack risk
Artificial Intelligence (AI) has applications in not just business and gaming but even health and fitness. It can predict threats to your health with increasing accuracy – one such health risk is a heart attack. Around 7.4 million people are living with heart disease in the UK, according to the British Heart Foundation. This is why proper prediction of heart attacks is the need of the day. A new paradigm combines new and old technologies to properly predict heart attacks.
- Europe > United Kingdom (0.27)
- North America > United States > Massachusetts (0.07)
AI Can Now Gauge Risk Of Death Caused By Cardiovascular Issues - Pioneering Minds
Researchers at MIT's Computer Science and Artificial Intelligence Laboratory (CSAIL) are using machine learning to estimate the risk of cardiovascular death. The system, RiskCardio, focuses on patients who have survived an acute coronary syndrome (ACS) and can better predict the risk of death caused by cardiovascular issues that block or reduce blood flow. Using just the first 15 minutes of a patient's raw electrocardiogram (ECG) signal, the tool produces a score that places patients into different risk categories, CSAIL explained. RiskCardio's technology uses just the patient's raw ECG signal to determine cardiovascular risk--without requiring any additional external patient information such as age or weight. If a patient with ASC checks into a hospital, a doctor can use RiskCardio's AI technology to determine the appropriate level of treatment.
AI estimates a person's risk of dying from heart disease in the next 30 days
Scientists in the US are using artificial intelligence (AI) to gauge a patient's risk of dying from heart disease. A team from the Massachusetts Institute of Technology created a system called RiskCardio. The technology was made for patients with acute coronary syndrome (ACS), which covers a range of conditions that suddenly reduce blood flow to the heart. RiskCardio works off just 15 minutes of a patient's'raw electrocardiogram (ECG) signal', which records the heart's rhythm and electrical activity. It then draws on a sample of ECG data to sort that particular patient into a'risk category'.
- North America > United States > Massachusetts (0.25)
- Asia > North Korea (0.06)
- North America > United States > Michigan (0.05)
Artificial Intelligence Can Now Gauge Your Risk of Cardiovascular Death
The benefits of AI in the health care spectrum are truly life-changing… and quite literally saving lives. Finally, some non-scary artificial intelligence (AI) news that won't scare the living bejeezus out of you: artificial intelligence has proven to be a key feather in the transformative cap of health care We are benefitted by AI when it can trumpet the need for preventative interventions by predicting such health threats as catching type 1 diabetes and helping predict breast cancer, along with its role in automated operations and precision surgery. Yes, the benefits of AI in the health care spectrum are truly life-changing… and quite literally saving lives. Researchers at MIT's Computer Science and Artificial Intelligence Laboratory (CSAIL) are using machine learning to estimate the risk of cardiovascular death. The system, RiskCardio, focuses on patients who have survived an acute coronary syndrome (ACS) and can better predict the risk of death caused by cardiovascular issues that block or reduce blood flow.
Using machine learning to estimate risk of cardiovascular death
Humans are inherently risk-averse: We spend our days calculating routes and routines, taking precautionary measures to avoid disease, danger, and despair. Still, our measures for controlling the inner workings of our biology can be a little more unruly. With that in mind, a team from MIT's Computer Science and Artificial Intelligence Laboratory (CSAIL) came up with a new system for better predicting health outcomes: a machine learning model that can estimate, from the electrical activity of their heart, a patient's risk of cardiovascular death. The system, called "RiskCardio," focuses on patients who have survived an acute coronary syndrome (ACS), which refers to a range of conditions where there's a reduction or blockage of blood to the heart. Using just the first 15 minutes of a patient's raw electrocardiogram (ECG) signal, the tool produces a score that places patients into different risk categories.
Using machine learning to estimate risk of cardiovascular death
Humans are inherently risk-averse: We spend our days calculating routes and routines, taking precautionary measures to avoid disease, danger, and despair. Still, our measures for controlling the inner workings of our biology can be a little more unruly. With that in mind, a team from MIT's Computer Science and Artificial Intelligence Laboratory (CSAIL) came up with a new system for better predicting health outcomes: a machine learning model that can estimate, from the electrical activity of their heart, a patient's risk of cardiovascular death. The system, called "RiskCardio," focuses on patients who have survived an acute coronary syndrome (ACS), which refers to a range of conditions where there's a reduction or blockage of blood to the heart. Using just the first 15 minutes of a patient's raw electrocardiogram (ECG) signal, the tool produces a score that places patients into different risk categories.